Cistanche Tubulosa
People mainly take Cistanche Tubulosa for mood, sleep, skin & hair. Based on 4 first-hand reports. Ranked #1515 of 1,974 overall.
7
User score
Not enough data0% positive0% mixed0% negative100% unclear
Of reports that state an outcome, 0% are positive.
Clinical research
Research pending
What Cistanche Tubulosa does, according to users
Of the people who reported each effect, the share who said it got better.
betterno changeworse
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
Research data for Cistanche Tubulosa is being compiled.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
700 mgas reported
Reported side effects
How often each side effect came up across all reports.
dry skin ×1itchy skin ×1insomnia ×1
What users say
Verbatim quotes, shortened only — each links to the original discussion.
“modern pharmacological studies have shown that echinacoside extracted from Cistanche tubulosa significantly enhanced testosterone biosynthesis”
“The new cistanche tubulosa is an excellent combo with the Tongkat if you haven’t tried it yet.”
“Cistanche tubulosa which increases serotonin levels likely through a novel gut microbiota pathway”
Top discussions (3)
Other options for mood
Resistance Training
Lifestyle · 53 reports
100% report better mood
Mostly positive
Retatrutide
Peptide · 298 reports
69% report better mood
Mostly positiveBResearch: Moderate
Caffeine + L-Theanine
Supplement · 46 reports
100% report better mood
Mostly positive
Tirzepatide
Medication · 219 reports
76% report better mood
Mostly positiveAResearch: Strong
Creatine Monohydrate
Supplement · 139 reports
88% report better mood
Mostly positiveAResearch: Strong
Magnesium Malate
Supplement · 103 reports
100% report better mood
Mostly positiveDResearch: None
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate